Moolec Science SA (NASDAQ:MLEC) Sees Significant Growth in Short Interest

Moolec Science SA (NASDAQ:MLECGet Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 8,000 shares, an increase of 56.9% from the March 31st total of 5,100 shares. Based on an average daily volume of 1,360,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.1% of the company’s shares are short sold.

Analysts Set New Price Targets

Separately, Maxim Group assumed coverage on Moolec Science in a research note on Tuesday, January 30th. They set a “buy” rating and a $6.00 price objective for the company.

Read Our Latest Stock Analysis on MLEC

Moolec Science Price Performance

Shares of NASDAQ:MLEC traded up $0.03 during mid-day trading on Friday, reaching $1.45. The stock had a trading volume of 308,796 shares, compared to its average volume of 4,393,164. The firm has a 50 day simple moving average of $1.53 and a two-hundred day simple moving average of $2.09. Moolec Science has a twelve month low of $1.15 and a twelve month high of $4.40. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.37 and a current ratio of 0.43.

Moolec Science (NASDAQ:MLECGet Free Report) last posted its earnings results on Wednesday, March 13th. The company reported ($0.05) earnings per share for the quarter, hitting the consensus estimate of ($0.05). The firm had revenue of $0.25 million during the quarter, compared to analyst estimates of $0.63 million.

Moolec Science Company Profile

(Get Free Report)

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product.

See Also

Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.